Search Site
Home >> Research Topics >> Respiratory System Research

Respiratory System Research

The respiratory system consists of the lungs, airways, diaphragm, trachea (windpipe) and pharynx (throat) and its primary function is the exchange of oxygen and carbon dioxide- breathing in and out. Between 6 and 10 liters of air are brought in and out of the lungs and 0.3 liters of oxygen are transferred from the alveoli to the blood per minute.

Respiratory System Research Products Areas

Products for Respiratory System Research

  1. Cat.No. Product Name Activity
  2. BCC6017 Amylin Endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptors Amylin
  3. BCC5962 α-CGRP (human) CGRP receptor agonist α-CGRP (human)
  4. BCC5712 CGRP (rat) Potent vasodilator CGRP (rat)
  5. BCC6043 CRSP-1 Endogenous central calcitonin receptor agonist CRSP-1
  6. BCC5869 PHM 27 (human) Potent calcitonin receptor agonist; endogenous analog of human VIP PHM 27 (human)
  7. BCC7405 SUN-B 8155 Non-peptide calcitonin (CT) receptor agonist SUN-B 8155
  8. BCC6018 AC 187 Potent and selective amylin receptor antagonist AC 187
  9. BCC5724 CGRP 8-37 (human) CGRP1 receptor antagonist CGRP 8-37 (human)
  10. BCC5717 CGRP 8-37 (rat) CGRP1 receptor antagonist CGRP 8-37 (rat)
  11. BCC7916 SB 268262 Selective non-peptide CGRP1 antagonist SB 268262
  12. BCC5269 Acetaminophen Cyclooxygenase inhibitor; may be selective for COX-3 Acetaminophen
  13. BCC2097 Aspirin (Acetylsalicylic acid) Cyclooxygenase inhibitor; NSAID Aspirin (Acetylsalicylic acid)
  14. BCC1099 Celecoxib Selective cyclooxygenase-2 (COX-2) inhibitor Celecoxib
  15. BCC4439 Diclofenac Sodium Cyclooxygenase inhibitor; NSAID Diclofenac Sodium
  16. BCC7064 DuP 697 Cyclooxygenase-2 (COX-2) inhibitor DuP 697
  17. BCC4428 Etodolac Selective cyclooxygenase-2 (COX-2) inhibitor; NSAID Etodolac
  18. BCC1576 FK 3311 Cyclooxygenase-2 (COX-2) inhibitor FK 3311
  19. BCC3781 Flurbiprofen Cyclooxygenase inhibitor Flurbiprofen
  20. BCC7092 FR 122047 hydrochloride Cyclooxygenase (COX-1) inhibitor FR 122047 hydrochloride
  21. BCC4042 (S)-(+)-Ibuprofen Cyclooxygenase inhibitor (COX-1 > COX-2) (S)-(+)-Ibuprofen
  22. BCC3794 Indomethacin Cyclooxygenase inhibitor (COX-1 > COX-2) Indomethacin
  23. BCC6490 Naproxen Sodium Cyclooxygenase inhibitor Naproxen Sodium
  24. BCC7944 NCX 4040 NO-donating aspirin; anti-inflammatory and antitumor NCX 4040
  25. BCC6219 NCX 466 Cyclooxygenase-inhibiting nitric oxide donor NCX 466
  26. BCC6857 NS 398 Cyclooxygenase-2 (COX-2) inhibitor NS 398
  27. BCC3841 Piroxicam Cyclooxygenase-1 (COX-1) inhibitor Piroxicam
  28. BCN5607 Resveratrol Cyclooxygenase inhibitor Resveratrol
  29. BCC7111 SC 560 Cyclooxygenase-1 (COX-1) inhibitor SC 560
  30. BCC5948 SC 58125 Selective cyclooxygenase-2 (COX-2) inhibitor SC 58125
  31. BCC7809 SC 236 Selective cyclooxygenase-2 (COX-2) inhibitor SC 236
  32. BCC4861 Sulindac Cyclooxygenase inhibitor (following metabolism to sulindac sulfide) Sulindac
  33. BCC7391 Talniflumate Cyclooxygenase inhibitor. Also chloride channel blocker Talniflumate
  34. BCC7419 Tenidap NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3 Tenidap
  35. BCC4441 Valdecoxib Selective and potent COX-2 inhibitor Valdecoxib
  36. BCC5812 AF 12198 Potent, selective human type I IL-1 receptor antagonist AF 12198
  37. BCC7149 YM 90709 Interleukin-5 receptor antagonist YM 90709
  38. BCC5895 Lyn peptide inhibitor Inhibits Lyn-dependent activities of IL-5 receptor; cell-permeable Lyn peptide inhibitor
  39. BCC5813 Ro 26-4550 trifluoroacetate Competitive inhibitor of IL-2/ IL-2Rα receptor interaction Ro 26-4550 trifluoroacetate
  40. BCC2520 AEE788 (NVP-AEE788) Potent EGFR and VEGFR inhibitor AEE788 (NVP-AEE788)
  41. BCC1051 AG-18 EGFR/PDGFR-kinase inhibitor AG-18
  42. BCC2193 AG-490 EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor AG-490
  43. BCC6722 AG 494 Potent EGFR-kinase inhibitor AG 494
  44. BCC6721 AG 555 Potent EGFR-kinase inhibitor AG 555
  45. BCC6720 AG 556 EGFR-kinase inhibitor AG 556
  46. BCC7113 AG 825 Selective ErbB2 inhibitor AG 825
  47. BCC4514 Tyrphostin AG 879 ErbB2 inhibitor Tyrphostin AG 879
  48. BCC6667 AG 99 EGFR-kinase inhibitor AG 99
  49. BCC5120 AV-412 free base Potent inhibitor of EGFR, ErbB2 and Abl receptor tyrosine kinases AV-412 free base
  50. BCC7356 BIBU 1361 dihydrochloride Selective inhibitor of EGFR-kinase BIBU 1361 dihydrochloride
  51. BCC1001 Adrenomedullin (1-12), human Potent, selective EGFR and ErbB2 inhibitor Adrenomedullin (1-12), human
  52. BCC1449 Canertinib dihydrochloride Potent EGFR kinase inhibitor Canertinib dihydrochloride
  53. BCC7667 CGP 52411 EGFR inhibitor. Also inhibits Aβ 42 fibril formation CGP 52411
  54. BCC1306 3,3'-Diindolylmethane Induces apoptosis; also inhibits EGFR activation 3,3'-Diindolylmethane
  55. BCN5499 Genistein EGFR kinase inhibitor. Also estrogen and PPARγ ligand Genistein
  56. BCC7300 GW 583340 dihydrochloride Potent dual EGFR/ErbB2 inhibitor; orally active GW 583340 dihydrochloride
  57. BCC7441 HDS 029 Potent inhibitor of the ErbB receptor family HDS 029
  58. BCC6046 HKI 357 Dual irreversible inhibitor of ErbB2 and EGFR HKI 357
  59. BCN2173 Gefitinib Orally active, selective EGFR inhibitor Gefitinib
  60. BCC7662 JNJ 28871063 hydrochloride Potent ErbB receptor family inhibitor JNJ 28871063 hydrochloride
  61. BCN1808 Lavendustin A EGFR, p60c-src inhibitor Lavendustin A
  62. BCC6702 Methyl 2,5-dihydroxycinnamate EGFR-kinase inhibitor Methyl 2,5-dihydroxycinnamate
  63. BCC7434 PD 158780 Potent ErbB receptor family inhibitor PD 158780
  64. BCC7486 PP 3 EGFR-kinase inhibitor. Also Src kinase negative control PP 3
  65. BCC4513 Mubritinib (TAK 165) Potent and selective ErbB2 inhibitor Mubritinib (TAK 165)
  66. BCC6703 Tyrphostin B44, (-) enantiomer EGFR-kinase inhibitor Tyrphostin B44, (-) enantiomer
  67. BCC6704 Tyrphostin B44, (+) enantiomer EGFR-kinase inhibitor Tyrphostin B44, (+) enantiomer
  68. BCC2202 WHI-P154 Potent EGFR inhibitor. Also inhibits JAK3 WHI-P154
  69. BCC2368 Sivelestat sodium salt Selective leukocyte elastase inhibitor Sivelestat sodium salt
  70. BCN2203 Corticosterone Endogenous glucocorticoid Corticosterone
  71. BCC4907 Fluticasone propionate Selective high affinity glucocorticoid receptor agonist Fluticasone propionate
  72. BCC6115 GSK 9027 Glucocorticoid receptor agonist GSK 9027
  73. BCC2256 Methylprednisolone Glucocorticoid receptor agonist Methylprednisolone
  74. BCC4801 Mometasone furoate Synthetic corticosteroid; anti-inflammatory agent Mometasone furoate
  75. BCC4486 Mifepristone Glucocorticoid and progesterone receptor antagonist Mifepristone
  76. BCC4767 Budesonide Synthetic glucocorticoid; anti-inflammatory and chemopreventive Budesonide
  77. BCC1184 Dexamethasone (DHAP) Anti-inflammatory glucocorticoid Dexamethasone (DHAP)
  78. BCN2192 Hydrocortisone Adrenal glucocorticoid; immunosuppressant Hydrocortisone
  79. BCC7576 BAY-u 9773 Dual CysLT1 and CysLT2 antagonist BAY-u 9773
  80. BCC7244 Cinalukast Potent, selective CysLT1 (LTD4) antagonist; orally active Cinalukast
  81. BCC7310 FPL 55712 Leukotriene receptor antagonist FPL 55712
  82. BCC7334 MK 571 Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor MK 571
  83. BCC4680 Montelukast Sodium CysLT1 and GPR17 antagonist Montelukast Sodium
  84. BCC4827 Pranlukast Selective CysLT1 antagonist Pranlukast
  85. BCC7180 SR 2640 hydrochloride Potent, selective LTD4 /LTE4 receptor antagonist SR 2640 hydrochloride
  86. BCC6274 Gue 1654 Selective inhibitor of OXE-R Gβ γ signaling Gue 1654
  87. BCN2215 Arachidonic acid Endogenous free fatty acid (in water-soluble emulsion) Arachidonic acid
  88. BCC6038 BAY-X 1005 Orally active 5-lipoxygenase activating protein (FLAP) inhibitor BAY-X 1005
  89. BCC7457 Cilastatin sodium Dipeptidase inhibitor; inhibits metabolism of LTD4 to LTE4 Cilastatin sodium
  90. BCC7017 MK 886 Inhibitor of 5-lipoxygenase-activating protein (FLAP) MK 886
  91. BCC6717 17-ODYA LTB ω -hydroxylase inhibitor 17-ODYA
  92. BCN5599 Baicalein 5- and 12-Lipoxygenase inhibitor Baicalein
  93. BCC7013 BW-B 70C 5-Lipoxygenase inhibitor BW-B 70C
  94. BCC7504 PD 146176 Selective 15-lipoxygenase inhibitor PD 146176
  95. BCC7288 STEARDA Endogenous inhibitor of 5-lipoxygenase STEARDA
  96. BCC6735 2-TEDC 5-, 12-, 15-Lipoxygenase inhibitor 2-TEDC
  97. BCC2515 Zileuton Orally active 5-LOX inhibitor Zileuton
  98. BCC2370 ARP 100 Selective inhibitor of MMP-2 ARP 100
  99. BCC2371 ARP 101 Inhibitor of MMP-2 ARP 101
  100. BCC1223 Batimastat (BB-94) Potent, broad spectrum MMP inhibitor Batimastat (BB-94)
  101. BCC2373 CP 471474 Broad spectrum MMP inhibitor CP 471474

Items 1 to 100 of 619 total

       
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8.  
  9.  
  10. Last